scholarly journals Advances in new drug therapies for the management of sickle cell disease

2018 ◽  
Vol 6 (5) ◽  
pp. 329-343 ◽  
Author(s):  
Kenneth I. Ataga ◽  
Payal C. Desai
2021 ◽  
Author(s):  
Satashree Paul ◽  

Researchers at the Fulcrum Therapeutics developed a bioavailable drug candidate called FTX 6058 – (a novel small molecular fetal haemoglobin inducer for sickle cell disease) that can restore the body’s ability to produce fetal haemoglobin


2017 ◽  
Vol 117 (11) ◽  
pp. 20-21
Author(s):  
Diane S. Aschenbrenner

1974 ◽  
Vol 133 (4) ◽  
pp. 624-631 ◽  
Author(s):  
T. A. Bensinger

2020 ◽  
Vol 8 (4) ◽  
pp. 390-401 ◽  
Author(s):  
Taryn M. Allen ◽  
Lindsay M. Anderson ◽  
Samuel M. Brotkin ◽  
Jennifer A. Rothman ◽  
Melanie J. Bonner

Sign in / Sign up

Export Citation Format

Share Document